Skip to content
Global health equity is a complex problem that impacts every country, and the biotech industry can be part of the solution, according to panelists […]
Biotech can be part of the solution to health inequity – here’s how Read More »
The health care sector is not being hit by overall inflation – and prescription drug prices are seeing the lowest increases, says a new
Inflation’s not hitting health – and drug prices have lowest increases, says report Read More »
The biotechnology industry’s focus on diversity, equity, and inclusion (DEI) in recent years has brought about improvement, but we still have work to do,
Biotech leaders discuss how to build a more inclusive industry Read More »
The Biopharma Sustainability Roundtable published a guidance document which expands on strategic thinking and planning of biotechnology and pharma investor Environmental, Social, and Governance
How biopharma can better communicate about ESG Read More »
The U.S. Federal Trade Commission (FTC) announced last week that it will investigate the “prescription drug middleman industry,” demanding information and records regarding the
FTC will investigate six largest pharmacy benefit managers Read More »
One of the key lessons of the COVID-19 pandemic has been the need to strengthen government support for biotechnology, with direct funding but also
Top officials share a key COVID lesson: Governments must support biotech Read More »
Regenerative farming is not only beneficial for soil and crops but also improves the nutritional value of food, a recent study shows. Biotechnology can
Study reveals nutrition benefits of regenerative farming; biotech is helping Read More »
James A. Geraghty, a board director of five NASDAQ-listed biotech companies and author, joins a conversation with Paul Hastings, CEO of Nkarta Therapeutics and
‘Inside the Orphan Drug Revolution’ author speaks today – read an excerpt of the book Read More »
Legislation to reauthorize Food and Drug Administration (FDA) user fee agreements passed the House with bipartisan support Wednesday, and the Senate is expected to
House votes to reauthorize FDA user fees; Senate’s up next Read More »
A May 16 letter signed by 125 patient advocacy groups urges congressional leaders to restore the access to COVID treatment for the uninsured that
Patient groups urge lawmakers to restore access to COVID treatment Read More »
